Baxter International Inc. (BAX) SEC Filings & Earnings Calls

Increased leverage covenant suggests potential liquidity or earnings pressure.

“Amendment to increase net leverage ratio covenant for five quarters indicates need for financial flexibility.”

Debt tender offer may indicate balance sheet optimization or liquidity management

“Tender offers for senior notes due 2032-2051”

Key finance leadership departure could disrupt financial reporting and strategic planning

“Resignation of Interim CFO and Chief Accounting Officer; no immediate replacement named”

Higher-cost inventory from end of 2025 rolling through, pressuring margins

“results reflect the roll through of higher-cost inventory produced at the end of 2025” · word for word

Unfavorable comparison from reclassification of functional costs from SG&A to COGS

“unfavorable comparison to the prior year related to the reclassification of certain functional costs from SG&A to cost of sales” · word for word

Shipment and installation hold of Novum IQ LVP impacting Infusion Systems sales

“reduced sales within Infusion Systems, due to the previously disclosed shipment and installation hold of the Novum IQ LVP” · word for word

Novum LVP recall and shipment hold

“In July 2025, we elected to temporarily stop distributing and installing the Novum LVP in the U.S. and Canada, except in the case of medical necessity. The timing of the release of the shipment and installation hold remains uncertain. As a result, we expect no meaningful sales of Novum LVP while these holds are in effect.” · word for word

Tariff and trade policy uncertainty

“We currently expect that our results will continue to be adversely impacted by Section 122 duties and recently announced Section 301 tariffs that have been imposed following the judicial review of certain tariffs.” · word for word

Supply chain constraints

“We have experienced challenges to our global supply chain, including, as a result of adverse impacts from significant weather events like Hurricane Helene and other global macroeconomic and geopolitical events (including the ongoing conflict in Iran), which have had a negative impact on our results of operations and may do so in the future.” · word for word

Inflation and limited pricing power

“We have experienced and are likely in the future to continue to experience inflationary and other increases in manufacturing costs and operating expenses (including as a result of the aforementioned tariffs and conflicts) and are limited in our ability to pass these cost increases on to our customers in a timely manner or at all due to the longer term nature” · word for word

Novum LVP Recall and Shipment Hold

“In July 2025, we elected to temporarily stop distributing and installing the Novum LVP in the U.S. and Canada, except in the case of medical necessity.” · word for word

Tariff Impact on Results

“We currently expect that our results will continue to be adversely impacted by Section 122 duties that were imposed following the judicial review of certain tariffs.” · word for word

Supply Constraints

“The sales decline in the first quarter was primarily driven by supply constraints in the U.S. and international markets and softness in certain premix products in our injectables portfolio and lower demand in anesthesia globally.” · word for word

Organic sales decline in U.S. market indicates demand weakness.

“U.S. organic sales declined 4%.”

GAAP loss from continuing operations suggests ongoing profitability challenges.

“GAAP net loss from continuing operations of ($17) million.”

Operational and macroeconomic challenges

“Our performance in 2025 reflects the impact of certain macroeconomic and operational challenges, including the impact of global tariffs and clinical practice changes following Hurricane Helene.” · word for word

Low relative TSR and stock price decline

“The TSR for Baxter for the three-year period totaled approximately (60%), as compared to 86% for the S&P 500 Composite Index and 20% for the S&P 500 Health Care Index over the same period.” · word for word

Leadership transition risk

“My role as president and CEO is still in the early days, and I am encouraged by the engagement of our employees worldwide and by the progress underway across the company as we work to deliver strategically, operationally and commercially.” · word for word

Free cash flow significantly below target

“Free Cash Flow From Continuing Operations of $438 million, which was 44.5% of the annual incentive target of $985 million” · word for word

Regulatory actions

“While 'Right the First Time' metric was achieved at target, there were two new regulatory actions for 2025.” · word for word

Interim CFO appointment following departure of Joel Grade; search for permanent CFO ongoing.

“Anita Zielinski, Baxter’s CAO and Controller, named interim CFO following Joel Grade’s departure effective March 2026 while Baxter conducts its search for a permanent replacement” · word for word

CFO transition may cause temporary leadership uncertainty

“CFO transition to advisory role; interim CFO appointed; no disagreement with management”

Goodwill impairment of $485M in Front Line Care reporting unit indicates potential overpayment or underperformance.

“goodwill impairment charge of $485 million related to the Front Line Care reporting unit” · word for word

Deferred tax asset valuation allowance of $330M suggests uncertainty in future U.S. profitability.

“valuation allowance on the realizability of U.S. deferred tax assets of $330 million” · word for word

Adjusted EPS declined 24% YoY due to unfavorable product mix, non-recurring inventory adjustments, and higher tax rate.

“adjusted diluted EPS $0.44, decreasing 24% from the prior year driven primarily by unfavorable product mix, non-recurring items including inventory adjustments, and a higher effective tax rate”

U.S. operational sales declined 1% despite reported growth, indicating currency or pricing headwinds.

“U.S. sales from continuing operations in the fourth quarter totaled approximately $1.55 billion, increasing 3% on a reported basis and declining 1% on an operational basis” · word for word

Shipment and installation hold of Novum IQ LVP impacted infusion systems sales.

“reduced sales in infusion systems due to the previously disclosed shipment and installation hold of the Novum IQ LVP”

Demand Reset in IV Solutions

“new clinical practices implemented after Hurricane Helene appear to have reset demand levels in our IV solutions business and negatively impacted sales of certain of our premix products.” · word for word

High Debt and Deleveraging Constraints

“As of December 31, 2025, we had approximately $9.48 billion of indebtedness outstanding.” · word for word

Dividend Cut

“We recently decreased our quarterly dividend to $0.01 per share” · word for word

Integration and Separation Risks

“We may not achieve the anticipated benefits of our significant transactions, including the sale of our Kidney Care business and our acquisition of Hillrom.” · word for word

Reduced debt maturities; improved liquidity profile.

“Repurchased $1.04B in aggregate principal; no new debt issued.”

Increased leverage with $2B new debt, though used for refinancing existing obligations.

“Company issued $2B in senior notes and used proceeds to repay term loan and tender for existing notes.”

Covenant relief suggests potential leverage pressure or need for financial flexibility

“Amendment to increase maximum net leverage ratio for four quarters indicates company may have been at risk of breaching existing covenant.”

Leadership vacuum in pharmaceuticals segment; succession risk.

“Resignation of Group President, Pharmaceuticals, with no named successor.”

Novum LVP Recall and Shipment Hold

“we elected to temporarily stop distributing and installing the Novum LVP in the U.S. and Canada, except in the case of medical necessity. ... we currently expect it to be in place beyond 2025.” · word for word

IRS Transfer Pricing Examination

“we have recorded reserves for uncertain tax positions related to these transfer pricing matters for tax years 2019 through 2025. These reserves in aggregate are recorded to expense for approximately $300 million” · word for word

Tariff Impact on Results

“our results have been adversely affected by these events and we expect for our results to continue to be negatively affected by tariffs.” · word for word

Goodwill Impairment Risk - Front Line Care

“if there is a significant adverse change in our outlook for this business in the future, a goodwill impairment could arise at that time. As of September 30, 2025, the carrying amount of goodwill for our Front Line Care reporting unit was $2.00 billion.” · word for word

Credit Rating Downgrade Risk

“Moody's placed our senior secured rating and long-term debt rating and our commercial paper rating on review for downgrade.” · word for word

GAAP loss due to charges; IV Solutions softness post-Hurricane Helene; Medical Products segment declined

“GAAP net loss of $51M; Medical Products & Therapies sales declined 1%; IV solutions softness due to fluid conservation”